Over-expressed in keratinocytes of patients with AD; stimulates Th2 lymphocytes, mast cells, and eosinophils to release IL-5, -13, and -31; promotes Th2-type immunity; reduces filaggrin and claudin-1 expression; reduces skin barrier function. Here, CLDN1 is linked to Alzheimer disease.